JP6419707B2 - 卵胞同期化後の単回リコンビナントウシｆｓｈ - Google Patents

卵胞同期化後の単回リコンビナントウシｆｓｈ Download PDF

Info

Publication number
JP6419707B2
JP6419707B2 JP2015542272A JP2015542272A JP6419707B2 JP 6419707 B2 JP6419707 B2 JP 6419707B2 JP 2015542272 A JP2015542272 A JP 2015542272A JP 2015542272 A JP2015542272 A JP 2015542272A JP 6419707 B2 JP6419707 B2 JP 6419707B2
Authority
JP
Japan
Prior art keywords
rfsh
human mammal
use according
fsh
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2015542272A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016502523A5 (enExample
JP2016502523A (ja
Inventor
ソウザ，アレクサンドル
イサカ，ナオミ
キャリー，オード
ティボー，ドミニク
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ceva Sante Animale SA
Original Assignee
Ceva Sante Animale SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ceva Sante Animale SA filed Critical Ceva Sante Animale SA
Publication of JP2016502523A publication Critical patent/JP2016502523A/ja
Publication of JP2016502523A5 publication Critical patent/JP2016502523A5/ja
Application granted granted Critical
Publication of JP6419707B2 publication Critical patent/JP6419707B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/02—Breeding vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Environmental Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
JP2015542272A 2012-11-16 2013-11-15 卵胞同期化後の単回リコンビナントウシｆｓｈ Active JP6419707B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12306428.9A EP2732824A1 (en) 2012-11-16 2012-11-16 Compositions and methods for increasing reproduction performance in non human mammals using alpha-beta-linked follicle stimulating hormone
EP12306428.9 2012-11-16
PCT/EP2013/073928 WO2014076231A1 (en) 2012-11-16 2013-11-15 Single dose recombinant bovine fsh after follicular synchronisation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018129177A Division JP6823013B2 (ja) 2012-11-16 2018-07-06 卵胞同期化後の単回リコンビナントウシｆｓｈ

Publications (3)

Publication Number Publication Date
JP2016502523A JP2016502523A (ja) 2016-01-28
JP2016502523A5 JP2016502523A5 (enExample) 2016-12-22
JP6419707B2 true JP6419707B2 (ja) 2018-11-07

Family

ID=47221997

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2015542272A Active JP6419707B2 (ja) 2012-11-16 2013-11-15 卵胞同期化後の単回リコンビナントウシｆｓｈ
JP2018129177A Active JP6823013B2 (ja) 2012-11-16 2018-07-06 卵胞同期化後の単回リコンビナントウシｆｓｈ

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018129177A Active JP6823013B2 (ja) 2012-11-16 2018-07-06 卵胞同期化後の単回リコンビナントウシｆｓｈ

Country Status (10)

Country Link
US (2) US20150335713A1 (enExample)
EP (3) EP2732824A1 (enExample)
JP (2) JP6419707B2 (enExample)
CN (2) CN110433281A (enExample)
AU (1) AU2013346803B2 (enExample)
ES (1) ES2743763T3 (enExample)
MX (1) MX373765B (enExample)
RU (1) RU2679944C2 (enExample)
WO (1) WO2014076231A1 (enExample)
ZA (1) ZA201503404B (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2782584T3 (pl) 2011-11-23 2021-12-13 Therapeuticsmd, Inc. Naturalne skojarzone hormonalne formulacje i terapie zastępcze
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
MX2016014281A (es) 2014-05-22 2017-02-22 Therapeuticsmd Inc Formulaciones y terapias de reemplazo de combinación de hormonas naturales.
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
CN105727260A (zh) * 2016-02-03 2016-07-06 华侨大学 一种卵泡刺激素的长效制剂
US9931349B2 (en) 2016-04-01 2018-04-03 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
US11376220B2 (en) 2017-06-30 2022-07-05 Therio, LLC Single-injection methods and formulations to induce and control multiple ovarian follicles in bovine, caprine, ovine, camelid and other female animals
CN107173329A (zh) * 2017-07-07 2017-09-19 宣汉县蜀宣花牛养殖专业合作社 一种蜀宣花牛母牛繁殖方法
CL2018001347A1 (es) * 2018-05-18 2019-03-15 Centro De Biotecnologia Y Biomedicina Spa 94% Hormona folículo estimulante bovina recombinante, composición que la comprende y método para inducir superovulación y sincronización del celo en bovinos utilizando dicha hormona
CN114258302A (zh) * 2019-08-01 2022-03-29 法国诗华大药厂 用于预防和/或治疗隐孢子虫病的兽用组合物
EP4504238A1 (en) 2022-04-01 2025-02-12 Ceva Santé Animale Increase of ovum pick-up in bos taurus
WO2023187160A1 (en) 2022-04-01 2023-10-05 Ceva Sante Animale Stimulation of superovulation in bos taurus
CN116027053B (zh) * 2022-09-27 2024-10-08 华中农业大学 一种竞争型草鱼卵泡刺激素检测试剂盒及应用
CN117089512A (zh) * 2023-08-21 2023-11-21 山东奥克斯畜牧种业有限公司 一种促进卵泡同步发育的制剂及牛体外胚胎生产方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1729352A1 (ru) * 1987-11-25 1992-04-30 Украинский Научно-Исследовательский Институт Физиологии И Биохимии Сельскохозяйственных Животных Способ вызывани полиовул ции у коров-доноров при трансплантации эмбрионов
US6238890B1 (en) 1994-02-18 2001-05-29 Washington University Single chain forms of the glycoprotein hormone quartet
US5589457A (en) 1995-07-03 1996-12-31 Ausa International, Inc. Process for the synchronization of ovulation
JPH09104638A (ja) * 1995-10-06 1997-04-22 Mitsui Pharmaceut Inc 医薬・動物薬組成物
US20090036384A1 (en) 2005-12-02 2009-02-05 Parnell Laboratories (Aust) Pty Limited Increasing pregnancy rates
US8518881B2 (en) 2007-02-08 2013-08-27 Aspenbio Pharma, Inc. Methods for inducing superovulation in ungulates
BRPI0821097A2 (pt) 2007-11-30 2017-05-23 Aspenbio Pharma Inc aitividade de hormônio equino folículo estimulante recombinante
WO2009103965A1 (en) * 2008-02-19 2009-08-27 Asterion Limited Modified linkers
JP5435422B2 (ja) * 2009-07-21 2014-03-05 独立行政法人農業・食品産業技術総合研究機構 ウシの発情同期化法およびそのためのキット

Also Published As

Publication number Publication date
ES2743763T3 (es) 2020-02-20
EP3520807A1 (en) 2019-08-07
JP2016502523A (ja) 2016-01-28
AU2013346803A1 (en) 2015-05-21
CN104918631A (zh) 2015-09-16
JP2018168189A (ja) 2018-11-01
ZA201503404B (en) 2016-08-31
WO2014076231A1 (en) 2014-05-22
RU2015122887A (ru) 2017-01-10
US20150335713A1 (en) 2015-11-26
JP6823013B2 (ja) 2021-01-27
MX373765B (es) 2020-03-24
US20190200587A1 (en) 2019-07-04
EP2732824A1 (en) 2014-05-21
RU2679944C2 (ru) 2019-02-14
EP2919803B1 (en) 2019-05-08
CN110433281A (zh) 2019-11-12
MX2015006141A (es) 2015-08-05
AU2013346803B2 (en) 2018-03-15
EP2919803A1 (en) 2015-09-23

Similar Documents

Publication Publication Date Title
JP6419707B2 (ja) 卵胞同期化後の単回リコンビナントウシｆｓｈ
US20120046518A1 (en) Estrus Synchronization Preparations & Effective CIDR-Less Protocols
Baruselli et al. Control of buffalo follicular dynamics for artificial insemination, superovulation and in vitro embryo production
JP2016502523A5 (enExample)
JPS6241690B2 (enExample)
US8835386B2 (en) Activity of recombinant equine follicle stimulating hormone
CN114515333A (zh) 用于促进雌性哺乳动物发情的产品与方法
US20220143131A1 (en) Compositions and Methods for increasing Reproduction Performance in Non Human Mammals Using Recombinant Luteinizing Hormone
WO2020061612A1 (en) Method for enhancing assisted breeding techniques
EP4504238A1 (en) Increase of ovum pick-up in bos taurus
BG107703A (bg) Метод за стартиране на цикъла при женски домашни животни
RU2617042C2 (ru) Способ индукции суперовуляции у коров-доноров эмбрионов с пролонгированием действия гипофизарных гонадотропинов
Hien Applications of PMSG and HCG in assisted reproductive technology in animals
Velladurai et al. Synchronization of Ovulation in Bovines—A Review
Kharche et al. Superovulatory response and embryo production efficiency in goats following pretreatment with heG and estradiol-I7B
WO2023187160A1 (en) Stimulation of superovulation in bos taurus
JPH03117446A (ja) Ｆｓｈによる牛の双子生産方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20161028

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20161028

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170801

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20180306

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180706

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20180820

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20180911

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20181010

R150 Certificate of patent or registration of utility model

Ref document number: 6419707

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250